About The Vertical Group
The Vertical Group is a venture capital firm founded in 1988. It is primarily based out of Basking Ridge, United States. As of Jan 2026, The Vertical Group has invested in 46 companies. It primarily invests in Series B round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to HealthTech and High Tech. Most recently it participated in the $***** Series F round of Route 92 Medical Overall, The Vertical Group portfolio has seen 7 IPOs and 25 acquisitions including key companies like Hinge Health, Omada and Masimo. A lot of funds co-invest with The Vertical Group, with names like USVP sharing a substantial percentage of its portfolio. The Vertical Group has team of 10 people including 6 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series B, Series A & 4 more
Portfolio Acquisitions
Portfolio Soonicorns
Deals in last 12 months
The Vertical Group's List of Top Investments
The Vertical Group has a portfolio of 46 companies. Their most notable investments are in PhotoThera and PhotoThera.Their portfolio spans across United States and Netherlands. They have invested in Life Sciences, HealthTech, High Tech and 5 other sectors, across stages such as Series B, Series A and 4 more. Here is the list of top investments by The Vertical Group:
1. Hinge Health
Provider of virtual physical therapy and digital pain care solutions. It offers personalized care combining expert clinical care and advanced technology. The platform includes exercise demonstrations, personalized goal setting, and communication with a care team. A women's pelvic health program is also available, addressing various needs throughout a woman's life. The company aims to improve mobility, aid injury recovery, and prepare patients for surgery.
Key facts about Hinge Health
- Founded Year: 2015
- Location: San Francisco (United States)
- Stage: Public
- Total Funding till date: $854M
- Employee Count: 1,655 as on Apr 30, 2026
- Investors: Tiger Global Management, Vitruvian Partners and 14 Others
- Latest Funding Round: Series E, Oct 22, 2021, $*****
- Highlight: Public
2. Omada
Provider of virtual care programs to manage chronic diseases. The company provides access to personal health coaches and specialists for virtual programs to deliver personalized interventions for prediabetes, diabetes, hypertension, and musculoskeletal issues.
Key facts about Omada
- Founded Year: 2011
- Location: San Francisco (United States)
- Stage: Public
- Total Funding till date: $450M
- Employee Count: 976 as on Apr 30, 2026
- Investors: Fidelity Investments, New Enterprise Associates and 44 Others
- Latest Funding Round: Series E, Feb 23, 2022, $*****
- Highlight: Public
3. Masimo
Provider of wide range of devices to monitor health parameters. The company offers a wide range of products across various categories include wearables Masimo W1 that provides untethered continuous pulse oximetry with visual and haptic notifications, Masimo W1 sport to track hydration levels, wireless earbuds with Masimo Adaptive Acoustic Technology for personalized sound, and Baby Monitoring Masimo Stork that tracks temperature, pulse rate, and oxygen saturation.
Key facts about Masimo
- Founded Year: 1989
- Location: Irvine (United States)
- Annual Revenue: $1.53B as on Dec 31, 2025
- Last Known Valuation: $*****
- Stage: Acquired
- Employee Count: 3,667 as on Apr 30, 2026
- Investors: Cota Capital, JPMorgan Chase and 8 Others
- Latest Funding Round: Post IPO, Aug 16, 2022, $*****
- Highlight: Acquired
Provider of hemodialysis machine with touchscreen display. The company's product "Tablo" is a hemodialysis machine with a touchscreen display, which offers step-by-step pictures and conversational instructions.
Key facts about Outset Medical
- Founded Year: 2003
- Location: San Jose (United States)
- Annual Revenue: $119M as on Dec 31, 2025
- Stage: Public
- Total Funding till date: $458M
- Employee Count: 571 as on Apr 30, 2026
- Investors: Fidelity Investments, Hercules Capital and 10 Others
- Latest Funding Round: Post IPO, Jan 03, 2025, $*****
- Highlight: Public
Silk Road Medical produces devices for Transcarotid artery revascularization (TAR) procedure for carotid artery disease. Their products include the EnRoute Transcarotid Neuroprotection and the EnRoute Stent system. The ENROUTE Transcarotid Stent is intended to be used in conjunction with the Transcarotid Neuroprotection System (NPS) during the TCAR procedure. A small incision is made just above the collar bone to expose the common carotid artery in which a flexible sheath is placed directly into the carotid artery and connected to a system that will reverse the flow of blood away from the brain to protect against fragments of plaque. The blood is filtered and returned through a second sheath placed in the femoral vein in the patient’s thigh. The Neuroprotection system allows balloon angioplasty and stenting to be performed while blood flow is reversed. After the stent is placed successfully to stabilize the plaque in the carotid artery, flow reversal is turned off and blood flow to the brain resumes in its normal direction.
Key facts about Silk Road Medical
- Founded Year: 2007
- Location: Sunnyvale (United States)
- Annual Revenue: $177M as on Dec 31, 2023
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $189M
- Employee Count: 197 as on Apr 30, 2026
- Investors: Norwest, Warburg Pincus and 2 Others
- Latest Funding Round: Series F, Jul 19, 2017, $*****
- Highlight: Acquired
The Vertical Group's Year-on-Year Investment Trends
The Vertical Group has invested in 47 companies over the last 25 years, with an average of 1 new investment annually in the last 10 years. In 2025, it made 1 investment, while as of Jan 2026, it has made 1 investment in this year. Its most recent first time investment was in Luminopia and most recent follow-on round was in Route 92 Medical.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 1 | 1 |
2025 | 0 | 1 | 1 |
2024 | 0 | 1 | 1 |
2023 | 0 | 2 | 2 |
2022 | 2 | 1 | 3 |
2021 | 1 | 0 | 1 |
2020 | 1 | 1 | 2 |
2019 | 0 | 0 | 0 |
2018 | 0 | 1 | 1 |
2017 | 2 | 2 | 4 |
The Vertical Group's Investments by Stage
The Vertical Group has made 9 investments in Series B stage with an average round size of $30.7M, 7 investments in Series A stage with an average round size of $19.4M and 7 investments in Series C stage with an average round size of $22M.Stage of entry | No. of Investments |
|---|---|
Series B | 9 |
Series A | 7 |
Series C | 7 |
Series E | 3 |
Seed | 2 |
Others | 1 |
Note: We have considered here, only first round of investments
The Vertical Group's Investments by Sector
The Vertical Group has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, HealthTech, Healthcare and High Tech. Notably, it has invested in 39 Tech companies, 37 Enterprise (B2B) companies, 16 Software companies and at least 16 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Life Sciences | 24 |
Enterprise Applications | 4 |
HealthTech | 4 |
Healthcare | 2 |
High Tech | 2 |
Others | 3 |
Note: We have considered here, only first round of investments
The Vertical Group's Investments by Geography
The Vertical Group has made most investments in United States (29).The Vertical Group's recent investments
The Vertical Group has made 1 investments in 2026 so far - Route 92 Medical.Here are the most recent investments by The Vertical Group:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jan 13, 2026 | United States | Series F | 1918 | [+4] | |
Mar 05, 2025 | United States | Series F | 4411 | [+6] | |
Jun 28, 2024 | United States | Series F | 8421 | [+3] | |
Nov 15, 2023 | United States | Series F | 4595 | [+2] | |
Jun 27, 2023 | United States | Series A | 9564 | [+1] |
IPOs and Publicly Listed companies in The Vertical Group's Portfolio
7 of The Vertical Group's portfolio companies have become public. CARLSMED got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jul 2025 at marketcap of $398M and Omada got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $1.06B.Here are The Vertical Group's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jul 23, 2025 | Dec 16, 2020 | Series A | 7662 | |
Jun 06, 2025 | Mar 21, 2013 | Series A | 5648 | |
May 22, 2025 | Jul 24, 2017 | Series A | 4693 | |
Mar 25, 2021 | - | - | 5197 | |
Sep 15, 2020 | May 19, 2015 | Series B | 2321 |
_1571286625316.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Acquired companies in The Vertical Group's Portfolio
25 companies from The Vertical Group's portfolio have been acquired. The most recent acquisition was Masimo in Feb 2026 by Danaher for $*****.Here are The Vertical Group's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Feb 17, 2026 | - | - | 5727 | |
Jun 18, 2024 | Apr 24, 2012 | Series B | 4032 | |
Jul 11, 2022 | Aug 21, 2014 | Series C | 4464 | |
Jul 27, 2021 | Jun 06, 2007 | Series B | 3162 | |
Nov 04, 2019 | - | - | 6003 |
Team profile of The Vertical Group
The Vertical Group has a team of 10 members including 6 Partners and 1 Principal located in United States, United Kingdom and 1 more location. The Vertical Group's team does not sit on the board of any company as of now.Here is a list of all team members in The Vertical Group:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | East Hampton | - | ||
Partner | Boca Raton | - | ||
Partner | Basking Ridge | - | ||
Partner | Basking Ridge | - | ||
Partner | Basildon | - | - | |
Partner | Toronto | - | - | |
Principal | Boise | - | - |
Co-investors of The Vertical Group
Over the past 25 years, 175 investors have co-invested in The Vertical Group's portfolio companies. This includes funds and angels.
- Invested before The Vertical Group: Rock Health, Edventure Holdings and 32 others have invested in rounds before The Vertical Group. There is 1 company where Rock Health has invested before The Vertical Group and 1 company where Edventure Holdings has invested before The Vertical Group.
- Top Co-investors of The Vertical Group: 60 investors entered a company along with The Vertical Group. These include investors like USVP (7 companies).
- Invested after The Vertical Group: A total of 81 investors have invested in The Vertical Group's portfolio after their investments. Top Investors include Norwest (2 companies), Fidelity Investments (2 companies) and Perceptive Advisors (2 companies).
Recent News related to The Vertical Group
•
Route 92 Medical Receives $50M in Growth FinancingFinSMEs•Apr 07, 2026•Norwest, Route 92 Medical, Sectoral, InnovaHealth Partners and 3 others
•
•
MicroTransponder receives $65m to advance stroke care with VivistimMedicalDeviceNetwork•Mar 13, 2025•MicroTransponder, Usventure, Exceller Hunt, Green Park & Golf Ventures and 6 others
•
MicroTransponder Secures $65 Million to Enhance Vivistim Adoption for Chronic Stroke RecoveryPR Newswire•Mar 12, 2025•MicroTransponder, Usventure, USVP, Osage Partners and 7 others
•
Route 92 Medical Attracts $50 Million in Equity FinancingMedical Product Outsourcing•Oct 14, 2024•Route 92 Medical, Novo Holdings, USVP, Norwest Venture Partners and 2 others
•
Stroke devicemaker Route 92 Medical raises $50M to go globalFierce Biotech•Sep 23, 2024•Route 92 Medical, Novo Holdings, USVP, Norwest Venture Partners and 2 others
•
Route 92 Medical Raises Over $31M in Series F Equity FinancingFinSMEs•Nov 17, 2023•Route 92 Medical, USVP, Norwest Venture Partners, InnovaHealth Partners and 1 other
•
•
Luminopia, Inc. Announces Closing of Oversubscribed Series A Financing RoundBusiness Wire•Jun 27, 2023•Luminopia, USVP, ShangBay Capital, The Vertical Group and 1 other
•
Vertical Group excited by rising demand for flexible office spacecrast.net•Apr 13, 2023•The Vertical Group
